No association between myeloproliferative neoplasms and the Crohn's disease-associated STAT3 predisposition SNP rs744166

被引：3
作者：
Jones, Amy V.
Cross, Nicholas C. P. [1 ]
机构：
[1] Univ Southampton, Wessex Reg Genet Lab, Salisbury, Wilts, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 07期
关键词：
GENOME-WIDE ASSOCIATION; CONFERS SUSCEPTIBILITY; POLYCYTHEMIA-VERA; JAK2; HAPLOTYPE;
D O I：
10.3324/haematol.2010.023390
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1226 / 1227
页数：2
相关论文
共 11 条
  • [1] [Anonymous], 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911
  • [2] Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
    Barrett, Jeffrey C.
    Hansoul, Sarah
    Nicolae, Dan L.
    Cho, Judy H.
    Duerr, Richard H.
    Rioux, John D.
    Brant, Steven R.
    Silverberg, Mark S.
    Taylor, Kent D.
    Barmada, M. Michael
    Bitton, Alain
    Dassopoulos, Themistocles
    Datta, Lisa Wu
    Green, Todd
    Griffiths, Anne M.
    Kistner, Emily O.
    Murtha, Michael T.
    Regueiro, Miguel D.
    Rotter, Jerome I.
    Schumm, L. Philip
    Steinhart, A. Hillary
    Targan, Stephan R.
    Xavier, Ramnik J.
    Libioulle, Cecile
    Sandor, Cynthia
    Lathrop, Mark
    Belaiche, Jacques
    Dewit, Olivier
    Gut, Ivo
    Heath, Simon
    Laukens, Debby
    Mni, Myriam
    Rutgeerts, Paul
    Van Gossum, Andre
    Zelenika, Diana
    Franchimont, Denis
    Hugot, Jean-Pierre
    de Vos, Martine
    Vermeire, Severine
    Louis, Edouard
    Cardon, Lon R.
    Anderson, Carl A.
    Drummond, Hazel
    Nimmo, Elaine
    Ahmad, Tariq
    Prescott, Natalie J.
    Onnie, Clive M.
    Fisher, Sheila A.
    Marchini, Jonathan
    Ghori, Jilur
    [J]. NATURE GENETICS, 2008, 40 (08) : 955 - 962
  • [3] Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
    Brand, S.
    [J]. GUT, 2009, 58 (08) : 1152 - 1167
  • [4] Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia
    Harrison, CN
    Campbell, PJ
    Buck, G
    Wheatley, K
    East, CL
    Bareford, D
    Wilkins, BS
    van der Walt, JD
    Reilly, JT
    Grigg, AP
    Revell, P
    Woodcock, BE
    Green, AR
    Pearson, TC
    Conneally, E
    Crawley, C
    Cross, NCP
    Hall, G
    Hunt, B
    Lucas, G
    Ludlam, C
    McMullin, MF
    Oscier, D
    Radia, D
    Reilly, JT
    Robinson, G
    Culligan, DJ
    Tighe, J
    Watson, HG
    Warren, AJ
    Awaad, MO
    Obeid, D
    Cuthbert, RJG
    Kyle, A
    Chan-Lam, D
    Paul, B
    Cuthbert, RJG
    McMullin, MF
    Morris, TCM
    Johnson, RJ
    Fegan, C
    Milligan, DW
    Galloway, MJ
    Williamson, PJ
    Newton, LJ
    Williams, AT
    Abboudi, Z
    Ryan, K
    Lush, R
    Blundell, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01) : 33 - 45
  • [5] JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
    Jones, Amy V.
    Chase, Andrew
    Silver, Richard T.
    Oscier, David
    Zoi, Katerina
    Wang, Y. Lynn
    Cario, Holger
    Pahl, Heike L.
    Collins, Andrew
    Reiter, Andreas
    Grand, Francis
    Cross, Nicholas C. P.
    [J]. NATURE GENETICS, 2009, 41 (04) : 446 - 449
  • [6] Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha
    Jones, AV
    Silver, RT
    Waghorn, K
    Curtis, C
    Kreil, S
    Zoi, K
    Hochhaus, A
    Oscier, D
    Metzgeroth, G
    Lengfelder, E
    Reiter, A
    Chase, AJ
    Cross, NCP
    [J]. BLOOD, 2006, 107 (08) : 3339 - 3341
  • [7] A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
    Kilpivaara, Outi
    Mukherjee, Semanti
    Schram, Alison M.
    Wadleigh, Martha
    Mullally, Ann
    Ebert, Benjamin L.
    Bass, Adam
    Marubayashi, Sachie
    Heguy, Adriana
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Offit, Kenneth
    Stone, Richard M.
    Gilliland, D. Gary
    Klein, Robert J.
    Levine, Ross L.
    [J]. NATURE GENETICS, 2009, 41 (04) : 455 - 459
  • [8] Autoimmunity and the risk of myeloproliferative neoplasms
    Kristinsson, Sigurdur Y.
    Landgren, Ola
    Samuelsson, Jan
    Bjorkholm, Magnus
    Goldin, Lynn R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1216 - 1220
  • [9] The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera
    Olcaydu, D.
    Skoda, R. C.
    Looser, R.
    Li, S.
    Cazzola, M.
    Pietra, D.
    Passamonti, F.
    Lippert, E.
    Carillo, S.
    Girodon, F.
    Vannucchi, A.
    Reading, N. S.
    Prchal, J. T.
    Ay, C.
    Pabinger, I.
    Gisslinger, H.
    Kralovics, R.
    [J]. LEUKEMIA, 2009, 23 (10) : 1924 - 1926
  • [10] A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
    Olcaydu, Damla
    Harutyunyan, Ashot
    Jaeger, Roland
    Berg, Tiina
    Gisslinger, Bettina
    Pabinger, Ingrid
    Gisslinger, Heinz
    Kralovics, Robert
    [J]. NATURE GENETICS, 2009, 41 (04) : 450 - 454
12